Macarena Hernández-Jiménez, Ph.D.Chief Scientific Officer at AptaTargets S.L.Speaker
Agenda Sessions
First-in-Human Clinical Trial of ApTOLL, A New Aptamer to Reduce Inflammation
11:00amView Session